Cortechs.ai and EDAP TMS (EDAP) announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco, UCSF, Prostate Center. This milestone marks the first clinical application of OnQ Prostate’s patented RSI technology to guide focal therapy, demonstrating how advanced MR-imaging can improve lesion localization and targeting for urologists performing focal therapy. As the only FDA-cleared solution for RSI-MRI, OnQ Prostate uniquely provides more detailed information about the tissue microstructure that can help urologists more confidently identify which patients are the best candidates for focal therapy and which lesions should be targeted.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EDAP:
- EDAP TMS Reports Record Focal One® Sales and Growth in Prostate Cancer Procedures
- EDAP TMS reports preliminary Q4 sales of 11 Focal One systems
- EDAP TMS Appoints Joshua H. Levine to Board of Directors
- EDAP TMS appoints Joshua Levine to board of directors
- EDAP TMS announces first pancreatic cancer patient treated with HIFU tech